- Report
- March 2026
- 474 Pages
Global
From €5178EUR$5,850USD£4,517GBP
- Report
- March 2026
- 413 Pages
Global
From €5178EUR$5,850USD£4,517GBP
- Report
- May 2025
- 115 Pages
Global
From €4204EUR$4,750USD£3,668GBP
- Report
- May 2025
- 154 Pages
Global
From €4204EUR$4,750USD£3,668GBP
- Report
- August 2025
- 149 Pages
Global
From €2622EUR$2,963USD£2,288GBP
€3496EUR$3,950USD£3,050GBP
- Report
- July 2025
- 350 Pages
Global
From €4380EUR$4,949USD£3,822GBP
- Report
- July 2025
- 350 Pages
Global
From €4380EUR$4,949USD£3,822GBP
- Report
- June 2025
- 400 Pages
Global
From €4380EUR$4,949USD£3,822GBP
- Report
- November 2025
- 160 Pages
Global
From €3496EUR$3,950USD£3,050GBP
- Report
- November 2025
- 160 Pages
Global
From €3496EUR$3,950USD£3,050GBP
- Report
- November 2025
- 160 Pages
Global
From €3496EUR$3,950USD£3,050GBP
- Report
- October 2025
- 160 Pages
Global
From €3496EUR$3,950USD£3,050GBP
- Report
- February 2026
- 82 Pages
Global
From €3500EUR$4,236USD£3,160GBP
- Report
- May 2025
- 92 Pages
Global
From €3500EUR$4,236USD£3,160GBP
- Report
- March 2025
- 150 Pages
Global
From €3408EUR$3,850USD£2,973GBP
€4293EUR$4,850USD£3,745GBP
- Report
- March 2025
- 150 Pages
Global
From €3408EUR$3,850USD£2,973GBP
€4293EUR$4,850USD£3,745GBP
- Report
- October 2025
- 90 Pages
Global
From €4293EUR$4,850USD£3,745GBP
- Report
- July 2025
- 132 Pages
Global
From €4293EUR$4,850USD£3,745GBP
From €6638EUR$7,500USD£5,792GBP
- Report
- March 2025
- 142 Pages
Global
From €4293EUR$4,850USD£3,745GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more